INVION

invion-logo

Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of the PhotosoftTM technology by licensor The Cho Group, which is based in Hong Kong. The Cho Group has funded and successfully commercialised a number of unique, advanced technologies. Invion has an agreement with The Cho Group to conduct the clinical development of the PhotosoftTM technology globally. The Cho Group provides non-dilutive funding for the research into and clinical trials of PhotosoftTM via an R&D services agreement with Invion. The provision of non-dilutive funding is part of a global development strategy for PhotosoftTM.

#People #Website #More

INVION

Social Links:

Industry:
Biotechnology Product Research

Address:
East Kew, Victoria, Australia

Country:
Australia

Website Url:
http://www.inviongroup.com

Status:
Active

Contact:
+61 3 9081 6005

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Euro Google Maps Typekit MailChimp WordPress 5.5


Current Employees Featured

not_available_image

Dr Greg Collier
Dr Greg Collier Managing Director & Chief Executive Officer @ Invion
Managing Director & Chief Executive Officer

Official Site Inspections

http://www.inviongroup.com

  • Host name: 23.185.0.2
  • IP address: 23.185.0.2
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Invion"

About Invion โ€“ Invion

Invion is a clinical-stage life-science company that is leading the global research and development of the Photosoft technology for the treatment of a range of cancers, atherosclerosis and โ€ฆSee details»

Invion - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +61 3 9081 6005 Invion has been appointed exclusive distributor and licensee in Australia and New Zealand of the PhotosoftTM โ€ฆSee details»

Board and Management Profiles โ€“ Invion - inviongroup.com

He also currently sits on Stanford Medicineโ€™s Center for Asian Health Research and Education (CARE) Advisory Board where he helps shape and advance CAREโ€™s mission of enhancing the โ€ฆSee details»

Invion investor hub | ASX:IVX

Welcome to Invion's (ASX:IVX) investor hub. View and interact with market data, announcements, annual reports, and investor presentationsSee details»

Invion Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Oct 4, 2024 Invion has 3 employees across 2 locations and $3.69 m in annual revenue in FY 2024. See insights on Invion including office locations, competitors, revenue, financials, โ€ฆSee details»

ASX:IVX - Invion's Chair and CEO appointed to โ€ฆ

Invion's Executive Chair, Thian Chew, has been appointed to the Advisory Board of the Stanford University School of Medicine's Center for Asian Health Research and Education (CARE). The appointment will present opportunities โ€ฆSee details»

Invion - Overview, News & Similar companies | ZoomInfo.com

Oct 23, 2023 Invion contact info: Phone number: (302) 353-1190 Website: www.inviongroup.com What does Invion do? Invion is a clinical-stage life-sciences company โ€ฆSee details»

Welcome to the Invion investor hub!

We welcome our shareholders and prospective shareholders to join the ASX:IVX investor hub and engage with the community.See details»

Corporate Governance โ€“ Invion

Jun 30, 2023 Address : 100 Albert Road South Melbourne, VIC 3205 Phone : +61 3 9692 7222 Email : [email protected]See details»

Invion Company Profile | Management and Employees List

[email protected]: Invion Top Competitors. Company Employees Revenue Top technologies; Hua Medicine. n/a: $970 K: InteKrin Therapeutics Inc. n/a: $5.3 M: โ€ฆSee details»

Invion Limited (ASX: IVX) Company Profile & Overview - Stock โ€ฆ

Dec 6, 2024 Company profile for Invion Limited (ASX: IVX) with a description, list of executives, contact details and other key facts.See details»

Company Pipeline โ€“ Invion

Address : 100 Albert Road South Melbourne, VIC 3205 Phone : +61 3 9692 7222 Email : [email protected]See details»

ASX:IVX - Frequently Asked Questions (FAQs)

Invion has received a number of enquirers from shareholders and we believe several of these questions will be of interest to all investors. In an effort to promote investor engagement and a โ€ฆSee details»

Invion Ltd Company Summary & News ASX:IVX - abnnewswire.net

Sep 18, 2024 Invion Ltd (ASX:IVX) (OTCMKTS:IVIXF) (FRA:7C8) is a life-science company that is leading the global research and development of the Photosoft technology for the treatment โ€ฆSee details»

Teams Profile โ€“ Invion

Director Business Development, Starpharma. Program Manager, AusBiotech. Regulatory Affairs, Bayer CropScience. MBA Melb Business School, B. Applied Science RMITSee details»

ASX:IVX - Invion CEO, Thian Chew, outlines Invion's updated โ€ฆ

Invion CEO, Thian Chew, outlines Invion's updated human clinical trial program in our latest Corporate Presentation.See details»

Discovery and Development Experts โ€“ Invion - inviongroup.com

Seb has extensive career experience in the development of fine chemical products and in drug discovery. He was previously Project Leader of Pharmaceutical Chemicals Research at โ€ฆSee details»

Invion investor hub - investors.inviongroup.com

View share price, top shareholders, your shareholding, and interact with announcements for Invion.See details»

ASX:IVX - Latest research update on Invion from Pitt Street

Pitt Street Research analysts Stuart Roberts and Nick Sundich just published an update on Invion as the Company advances its clinical programs in 2024. Click on the link below to read the โ€ฆSee details»